Current and emerging treatment of multiple sclerosis.
FM Hart, J Bainbridge - The American journal of managed care, 2016 - europepmc.org
The treatment of multiple sclerosis (MS) falls into 3 categories: treatment of exacerbations,
slowing disease progression with disease-modifying therapies (DMTs), and symptomatic …
slowing disease progression with disease-modifying therapies (DMTs), and symptomatic …
[PDF][PDF] A review of current and emerging therapeutic strategies in multiple sclerosis
MJ Tullman - Am J Manag Care, 2013 - ptce.s3.amazonaws.com
Multiple sclerosis (MS) is a chronic immunemediated disease that potentially requires
symptomatic and disease-modifying therapies. Numerous symptoms (eg, fatigue, spasticity …
symptomatic and disease-modifying therapies. Numerous symptoms (eg, fatigue, spasticity …
Established and novel disease‐modifying treatments in multiple sclerosis
AH Cross, RT Naismith - Journal of internal medicine, 2014 - Wiley Online Library
Multiple sclerosis (MS) is a presumed autoimmune disorder of the central nervous system,
resulting in inflammatory demyelination and axonal and neuronal injury. New diagnostic …
resulting in inflammatory demyelination and axonal and neuronal injury. New diagnostic …
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies
DM Wingerchuk, JL Carter - Mayo Clinic Proceedings, 2014 - Elsevier
Multiple sclerosis (MS) is a chronic inflammatory demyelinating central nervous system
disease that typically strikes young adults, especially women. The pathobiology of MS …
disease that typically strikes young adults, especially women. The pathobiology of MS …
A changing treatment landscape for multiple sclerosis: challenges and opportunities
F Piehl - Journal of internal medicine, 2014 - Wiley Online Library
Multiple sclerosis (MS) is primarily an autoimmune disease of the central nervous system,
but also encompasses prominent neurodegenerative aspects. A significant proportion of MS …
but also encompasses prominent neurodegenerative aspects. A significant proportion of MS …
Long-term follow-up of clinical trials of multiple sclerosis therapies
MS Freedman - Neurology, 2011 - AAN Enterprises
Results from registry studies can provide valuable information about the prevalence and
clinical course of different forms of multiple sclerosis (MS). Such studies can also help …
clinical course of different forms of multiple sclerosis (MS). Such studies can also help …
Treatment of multiple sclerosis: current concepts and future perspectives
D Buck, B Hemmer - Journal of neurology, 2011 - Springer
Currently, several disease-modifying therapies for the treatment of multiple sclerosis are
established and more are likely to be introduced. These treatment options differ with respect …
established and more are likely to be introduced. These treatment options differ with respect …
New and emerging disease modifying therapies for multiple sclerosis
S Saidha, C Eckstein… - Annals of the New York …, 2012 - Wiley Online Library
Several disease‐modifying drugs (DMDs) are currently approved for the treatment of
multiple sclerosis (MS). Recently, there has been increased identification and development …
multiple sclerosis (MS). Recently, there has been increased identification and development …
Update on disease-modifying therapies for multiple sclerosis
DL Vargas, WR Tyor - Journal of Investigative Medicine, 2017 - journals.sagepub.com
Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous
system (CNS). It predominantly affects young women and is one of the most common causes …
system (CNS). It predominantly affects young women and is one of the most common causes …
Current disease‐modifying treatment of multiple sclerosis
J Derwenskus - Mount Sinai Journal of Medicine: A Journal of …, 2011 - Wiley Online Library
The treatment era for multiple sclerosis began in 1993 with the approval of the first disease‐
modifying therapy. This changed the management of multiple sclerosis from treating acute …
modifying therapy. This changed the management of multiple sclerosis from treating acute …